spacer
spacer

Jump to: InterProScan Databases Documentation FTP site Help Advanced search

InterPro: IPR000403 Phosphatidylinositol 3-/4-kinase, catalytic

Protein matchesHelp
UniProtKB
Matches:
1850 proteins
AccessionHelp IPR000403 PI3/4_kinase_cat
TypeHelp Domain
SignaturesHelp
InterPro RelationshipsHelp
Parent IPR011009 Protein kinase-like domain
Found in IPR008290 Phosphatidylinositol 3-kinase, Vps34 type
IPR015433 Phosphatidylinositol Kinase
IPR015519 Ataxia-Telangiectasia Mutated
Contains IPR003152 PIK-related kinase, FATC
IPR018936 Phosphatidylinositol 3- and 4-kinase, conserved site
GO Term annotationHelp
Function GO:0016773 phosphotransferase activity, alcohol group as acceptor
InterPro annotation
BioMart Logo Entry Details in BioMart
AbstractHelp

Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity [1]:

  • Serine/threonine-protein kinases
  • Tyrosine-protein kinases
  • Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins)

Protein kinase function has been evolutionarily conserved from Escherichia coli to human [2]. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation [3]. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [4], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases [5].

Phosphatidylinositol 3-kinase (PI3-kinase) (EC:2.7.1.137) [6] is an enzyme that phosphorylates phosphoinositides on the 3-hydroxyl group of the inositol ring. The three products of PI3-kinase - PI-3-P, PI-3,4-P(2) and PI-3,4,5-P(3) function as secondary messengers in cell signalling. Phosphatidylinositol 4-kinase (PI4-kinase) (EC:2.7.1.67) [7] is an enzyme that acts on phosphatidylinositol (PI) in the first committed step in the production of the secondary messenger inositol-1'4'5'-trisphosphate. This domain is also present in a wide range of protein kinases, involved in diverse cellular functions, such as control of cell growth, regulation of cell cycle progression, a DNA damage checkpoint, recombination, and maintenance of telomere length. Despite significant homology to lipid kinases, no lipid kinase activity has been demonstrated for any of the PIK-related kinases [8].

The PI3- and PI4-kinases share a well conserved domain at their C-terminal section; this domain seems to be distantly related to the catalytic domain of protein kinases [9, 10]. The catalytic domain of PI3K has the typical bilobal structure that is seen in other ATP-dependent kinases, with a small N-terminal lobe and a large C-terminal lobe. The core of this domain is the most conserved region of the PI3Ks. The ATP cofactor binds in the crevice formed by the N-and C-terminal lobes, a loop between two strands provides a hydrophobic pocket for binding of the adenine moiety, and a lysine residue interacts with the alpha-phosphate. In contrast to protein kinases, the PI3K loop which interacts with the phosphates of the ATP and is known as the glycine-rich or P-loop, contains no glycine residues. Instead, contact with the ATP -phosphate is maintained through the side chain of a conserved serine residue.

Structural linksHelp
Database linksHelp
PDBe-motif: PS00915 , PS00916
Enzyme: EC:2.7
PROSITE doc: PDOC00710
PANDIT: PF00454
Blocks: IPB000403
InteractionsHelp
This domain has been experimentally proven to be involved in Protein:Protein interactions.
Representative data is shown with the following example proteins:

Taxonomic coverageHelp

Overlapping InterPro entriesHelp
IPR000403 Numbers of overlapping proteins Average numbers of overlapping amino acids

Example proteinsHelp
O00443 Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing alpha polypeptide

O01510 Serine/threonine-protein kinase smg-1

P35169 Serine/threonine-protein kinase TOR1

Q5EAK6 Serine/threonine-protein kinase ATM

Q61194 Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing alpha polypeptide

More proteins


Example Proteins Key


InterPro entry accession number/name and structure databases Colour code
IPR009076 FKBP12-rapamycin-associated protein, FKBP12-rapamycin-binding
IPR014009 PIK-related kinase
IPR001263 Phosphoinositide 3-kinase, accessory (PIK) domain
IPR000403 Phosphatidylinositol 3-/4-kinase, catalytic
IPR018936 Phosphatidylinositol 3- and 4-kinase, conserved site
IPR000357 HEAT
IPR002420 Phosphoinositide 3-kinase, C2
IPR018029 C2 membrane targeting protein
IPR016024 Armadillo-type fold
IPR003152 PIK-related kinase, FATC
IPR000341 Phosphoinositide 3-kinase, ras-binding
IPR008973 C2 calcium/lipid-binding domain, CaLB
IPR011009 Protein kinase-like domain
IPR000008 C2 calcium-dependent membrane targeting
IPR003151 PIK-related kinase, FAT
IPR015519 Ataxia-Telangiectasia Mutated
IPR011989 Armadillo-like helical
IPR001683 Phox-like
IPR015433 Phosphatidylinositol Kinase
PDB Chain
ModBase
SWISS-MODEL

PublicationsHelp
1. Hanks SK, Quinn AM, Hunter T.
The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.
Science 241 42-52 1988 [PubMed: 3291115]
http://www.sciencemag.org/cgi/content/abstract/241/4861/42
2. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S.
The protein kinase complement of the human genome.
Science 298 1912-34 2002 [PubMed: 12471243]
http://dx.doi.org/10.1126/science.1075762
3. Manning G, Plowman GD, Hunter T, Sudarsanam S.
Evolution of protein kinase signaling from yeast to man.
Trends Biochem. Sci. 27 514-20 2002 [PubMed: 12368087]
http://dx.doi.org/10.1016/S0968-0004(02)02179-5
4. Stout TJ, Foster PG, Matthews DJ.
High-throughput structural biology in drug discovery: protein kinases.
Curr. Pharm. Des. 10 1069-82 2004 [PubMed: 15078142]
http://dx.doi.org/10.2174/1381612043452695
5. Li B, Liu Y, Uno T, Gray N.
Creating chemical diversity to target protein kinases.
Comb. Chem. High Throughput Screen. 7 453-72 2004 [PubMed: 15320712]
http://openurl.ingenta.com/content?genre=article&issn=1386-2073&volume=7&issue=5&spage=453
6. Hiles ID, Otsu M, Volinia S, Fry MJ, Gout I, Dhand R, Panayotou G, Ruiz-Larrea F, Thompson A, Totty NF.
Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit.
Cell 70 419-29 1992 [PubMed: 1322797]
http://dx.doi.org/10.1016/0092-8674(92)90166-A
7. Garcia-Bustos JF, Marini F, Stevenson I, Frei C, Hall MN.
PIK1, an essential phosphatidylinositol 4-kinase associated with the yeast nucleus.
EMBO J. 13 2352-61 1994 [PubMed: 8194527]
http://ukpmc.ac.uk/articlerender.cgi?tool=EBI&pubmedid=8194527
8. Crespo JL, Hall MN.
Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae.
Microbiol. Mol. Biol. Rev. 66 579-91, table of contents 2002 [PubMed: 12456783]
http://dx.doi.org/10.1128/MMBR.66.4.579-591.2002
9. Kunz J, Henriquez R, Schneider U, Deuter-Reinhard M, Movva NR, Hall MN.
Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression.
Cell 73 585-96 1993 [PubMed: 8387896]
http://dx.doi.org/10.1016/0092-8674(93)90144-F
10. Djordjevic S, Driscoll PC.
Structural insight into substrate specificity and regulatory mechanisms of phosphoinositide 3-kinases.
Trends Biochem. Sci. 27 426-32 2002 [PubMed: 12151228]
http://dx.doi.org/10.1016/S0968-0004(02)02136-9

Additional ReadingHelp
Schu PV, Takegawa K, Fry MJ, Stack JH, Waterfield MD, Emr SD.
Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting.
Science 260 1993 88-91 [PubMed: 8385367]
http://www.sciencemag.org/cgi/content/abstract/260/5104/88
Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP, Williams RL.
Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.
Mol. Cell 6 2000 909-19 [PubMed: 11090628]
http://dx.doi.org/10.1016/S1097-2765(05)00089-4
Steinbacher S, Hof P, Eichinger L, Schleicher M, Gettemans J, Vandekerckhove J, Huber R, Benz J.
The crystal structure of the Physarum polycephalum actin-fragmin kinase: an atypical protein kinase with a specialized substrate-binding domain.
EMBO J. 18 1999 2923-9 [PubMed: 10357805]
http://dx.doi.org/10.1093/emboj/18.11.2923
Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, Lane WS, Schreiber SL.
A mammalian protein targeted by G1-arresting rapamycin-receptor complex.
Nature 369 1994 756-8 [PubMed: 8008069]
http://dx.doi.org/10.1038/369756a0
Kato R, Ogawa H.
An essential gene, ESR1, is required for mitotic cell growth, DNA repair and meiotic recombination in Saccharomyces cerevisiae.
Nucleic Acids Res. 22 1994 3104-12 [PubMed: 8065923]
http://dx.doi.org/10.1093/nar/22.15.3104
Pacold ME, Suire S, Perisic O, Lara-Gonzalez S, Davis CT, Walker EH, Hawkins PT, Stephens L, Eccleston JF, Williams RL.
Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma.
Cell 103 2000 931-43 [PubMed: 11136978]
http://dx.doi.org/10.1016/S0092-8674(00)00196-3
Camps M, Ruckle T, Ji H, Ardissone V, Rintelen F, Shaw J, Ferrandi C, Chabert C, Gillieron C, Francon B, Martin T, Gretener D, Perrin D, Leroy D, Vitte PA, Hirsch E, Wymann MP, Cirillo R, Schwarz MK, Rommel C.
Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.
Nat. Med. 11 2005 936-43 [PubMed: 16127437]
http://dx.doi.org/10.1038/nm1284
Shi M, Vivian CJ, Lee KJ, Ge C, Morotomi-Yano K, Manzl C, Bock F, Sato S, Tomomori-Sato C, Zhu R, Haug JS, Swanson SK, Washburn MP, Chen DJ, Chen BP, Villunger A, Florens L, Du C.
DNA-PKcs-PIDDosome: a nuclear caspase-2-activating complex with role in G2/M checkpoint maintenance.
Cell 136 2009 508-20 [PubMed: 19203584]
http://dx.doi.org/10.1016/j.cell.2008.12.021
Knight ZA, Gonzalez B, Feldman ME, Zunder ER, Goldenberg DD, Williams O, Loewith R, Stokoe D, Balla A, Toth B, Balla T, Weiss WA, Williams RL, Shokat KM.
A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling.
Cell 125 2006 733-47 [PubMed: 16647110]
http://dx.doi.org/10.1016/j.cell.2006.03.035
spacer
spacer
InterPro 23.1